| Dr Nafeeza Farisa Aurup, MD | |
|
1 Capital Way, Pennington, NJ 08534-2520 | |
| (609) 303-4010 | |
| Not Available |
| Full Name | Dr Nafeeza Farisa Aurup |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 8 Years |
| Location | 1 Capital Way, Pennington, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467814749 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 25MA10654900 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Capital Health Medical Center - Hopewell | Pennington, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Capital Health Multispecialty Group | 1850689894 | 233 |
News Archive
Access to inpatient care for young people with mental health issues varies significantly across Europe, with mental health services providing up to fifty times more beds depending upon the country you live in.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted a Phase IIb protocol to the U.S. Food and Drug Administration (FDA) for the clinical study of Serdaxin for the treatment of major depressive disorder (MDD).
NOXXON Pharma today announced the treatment of the first cohort of three multiple myeloma (MM) patients in a Phase IIa clinical trial of its anti-CXCL12/SDF-1 (CXC chemokine ligand 12 / Stromal Cell-Derived Factor-1) Spiegelmer NOX-A12.
The use of specific medications following a heart attack has been shown to reduce cardiovascular events and mortality, however; while highly effective, the rate of adherence to these medications is poor. Researchers from Brigham and Women's Hospital (BWH) evaluated whether eliminating co-payments for these medications would increase adherence and improve outcomes in patients who have had a heart attack.
In a behind-the-scenes analysis of the U.S. Congress, Brown University political scientist Katrina Gamble found that black representatives put more time and resources than white representatives into developing policies and advocating for legislation of interest to African Americans.
› Verified 1 days ago
| Entity Name | Pegasus Emergency Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336179621 PECOS PAC ID: 5890789176 Enrollment ID: O20040409000575 |
News Archive
Access to inpatient care for young people with mental health issues varies significantly across Europe, with mental health services providing up to fifty times more beds depending upon the country you live in.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted a Phase IIb protocol to the U.S. Food and Drug Administration (FDA) for the clinical study of Serdaxin for the treatment of major depressive disorder (MDD).
NOXXON Pharma today announced the treatment of the first cohort of three multiple myeloma (MM) patients in a Phase IIa clinical trial of its anti-CXCL12/SDF-1 (CXC chemokine ligand 12 / Stromal Cell-Derived Factor-1) Spiegelmer NOX-A12.
The use of specific medications following a heart attack has been shown to reduce cardiovascular events and mortality, however; while highly effective, the rate of adherence to these medications is poor. Researchers from Brigham and Women's Hospital (BWH) evaluated whether eliminating co-payments for these medications would increase adherence and improve outcomes in patients who have had a heart attack.
In a behind-the-scenes analysis of the U.S. Congress, Brown University political scientist Katrina Gamble found that black representatives put more time and resources than white representatives into developing policies and advocating for legislation of interest to African Americans.
› Verified 1 days ago
| Entity Name | Hunterdon Urgent Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154791796 PECOS PAC ID: 9638460876 Enrollment ID: O20160620001504 |
News Archive
Access to inpatient care for young people with mental health issues varies significantly across Europe, with mental health services providing up to fifty times more beds depending upon the country you live in.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted a Phase IIb protocol to the U.S. Food and Drug Administration (FDA) for the clinical study of Serdaxin for the treatment of major depressive disorder (MDD).
NOXXON Pharma today announced the treatment of the first cohort of three multiple myeloma (MM) patients in a Phase IIa clinical trial of its anti-CXCL12/SDF-1 (CXC chemokine ligand 12 / Stromal Cell-Derived Factor-1) Spiegelmer NOX-A12.
The use of specific medications following a heart attack has been shown to reduce cardiovascular events and mortality, however; while highly effective, the rate of adherence to these medications is poor. Researchers from Brigham and Women's Hospital (BWH) evaluated whether eliminating co-payments for these medications would increase adherence and improve outcomes in patients who have had a heart attack.
In a behind-the-scenes analysis of the U.S. Congress, Brown University political scientist Katrina Gamble found that black representatives put more time and resources than white representatives into developing policies and advocating for legislation of interest to African Americans.
› Verified 1 days ago
| Entity Name | Capital Health Multispecialty Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083072342 PECOS PAC ID: 1850689894 Enrollment ID: O20161007000162 |
News Archive
Access to inpatient care for young people with mental health issues varies significantly across Europe, with mental health services providing up to fifty times more beds depending upon the country you live in.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted a Phase IIb protocol to the U.S. Food and Drug Administration (FDA) for the clinical study of Serdaxin for the treatment of major depressive disorder (MDD).
NOXXON Pharma today announced the treatment of the first cohort of three multiple myeloma (MM) patients in a Phase IIa clinical trial of its anti-CXCL12/SDF-1 (CXC chemokine ligand 12 / Stromal Cell-Derived Factor-1) Spiegelmer NOX-A12.
The use of specific medications following a heart attack has been shown to reduce cardiovascular events and mortality, however; while highly effective, the rate of adherence to these medications is poor. Researchers from Brigham and Women's Hospital (BWH) evaluated whether eliminating co-payments for these medications would increase adherence and improve outcomes in patients who have had a heart attack.
In a behind-the-scenes analysis of the U.S. Congress, Brown University political scientist Katrina Gamble found that black representatives put more time and resources than white representatives into developing policies and advocating for legislation of interest to African Americans.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nafeeza Farisa Aurup, MD 1 Capital Way, Pennington, NJ 08534-2520 Ph: () - | Dr Nafeeza Farisa Aurup, MD 1 Capital Way, Pennington, NJ 08534-2520 Ph: (609) 303-4010 |
News Archive
Access to inpatient care for young people with mental health issues varies significantly across Europe, with mental health services providing up to fifty times more beds depending upon the country you live in.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted a Phase IIb protocol to the U.S. Food and Drug Administration (FDA) for the clinical study of Serdaxin for the treatment of major depressive disorder (MDD).
NOXXON Pharma today announced the treatment of the first cohort of three multiple myeloma (MM) patients in a Phase IIa clinical trial of its anti-CXCL12/SDF-1 (CXC chemokine ligand 12 / Stromal Cell-Derived Factor-1) Spiegelmer NOX-A12.
The use of specific medications following a heart attack has been shown to reduce cardiovascular events and mortality, however; while highly effective, the rate of adherence to these medications is poor. Researchers from Brigham and Women's Hospital (BWH) evaluated whether eliminating co-payments for these medications would increase adherence and improve outcomes in patients who have had a heart attack.
In a behind-the-scenes analysis of the U.S. Congress, Brown University political scientist Katrina Gamble found that black representatives put more time and resources than white representatives into developing policies and advocating for legislation of interest to African Americans.
› Verified 1 days ago
Dr. Jessica Lynn Williams, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Capital Way, Pennington, NJ 08534 Phone: 609-303-4010 Fax: 609-537-6168 | |
Yoganand Deendyal, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Capital Way, Pennington, NJ 08534 Phone: 609-303-4000 | |
Brian C. Tucker, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Capital Way, Pennington, NJ 08534 Phone: 609-303-4010 Fax: 609-537-6168 | |
Joseph Victor Portale, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1 Capital Way, Pennington, NJ 08534 Phone: 609-303-4010 | |
Carlos Vaca, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Capital Way, Pennington, NJ 08534 Phone: 609-303-4010 Fax: 609-537-6168 | |
Saadia Mohsin, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Capital Way, Pennington, NJ 08534 Phone: 609-303-4000 | |
Jane S Wu, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Capital Way, Pennington, NJ 08534 Phone: 609-303-4010 Fax: 609-537-6168 |